CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 195 enrolled
Drug / intervention
SmartHeart Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04664881
NCT04664881N/ACompleted
CompareCT.gov

Home Telemonitoring In Patients After Myocardial Infarction, HELP ME Trial

Mayo Clinic·interventional·Posted Dec 11, 2020·Updated May 11, 2025

In Brief

A clinical study evaluating SmartHeart Device for Myocardial Infarction and Heart Attack. Completed, enrolled 195 participants across 1 site.

Detailed Summary

This study is being done to determine if taking an electrocardiogram (ECG) by a portable device (SmartHeart) followed by a phone call will improve patient outcomes by early recognition of abnormalities and decrease emergency room visits and hospital readmissions compared to standard therapy alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyocardial Infarction, Heart Attack
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 11, 2020
Enrollment StartOct 14, 2020
Primary CompletionMay 2, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 5.6 years ago

Interventions

SmartHeart Devicedevice

A body-worn device that allows an individual to immediately transmit a 12-lead ECG from anywhere and anytime, using a smartphone application to a physician's office, hospital or monitoring center where designated on-call staff interpret the ECG and make recommendations.